Growth Metrics

Evolus (EOLS) Common Equity (2017 - 2026)

Evolus filings provide 10 years of Common Equity readings, the most recent being -$28.8 million for Q1 2026.

  • On a quarterly basis, Common Equity fell 335.81% to -$28.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$28.8 million, a 335.81% decrease, with the full-year FY2025 number at -$23.1 million, down 518.44% from a year prior.
  • Common Equity hit -$28.8 million in Q1 2026 for Evolus, down from -$23.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $67.2 million in Q1 2022 to a low of -$28.8 million in Q1 2026.
  • Median Common Equity over the past 5 years was $5.5 million (2024), compared with a mean of $3.8 million.
  • Biggest five-year swings in Common Equity: skyrocketed 377.38% in 2024 and later tumbled 588.29% in 2025.
  • Evolus' Common Equity stood at $18.5 million in 2022, then crashed by 211.84% to -$20.7 million in 2023, then surged by 126.69% to $5.5 million in 2024, then tumbled by 518.44% to -$23.1 million in 2025, then dropped by 24.56% to -$28.8 million in 2026.
  • The last three reported values for Common Equity were -$28.8 million (Q1 2026), -$23.1 million (Q4 2025), and -$28.8 million (Q3 2025) per Business Quant data.